alovudine has been researched along with Adenocarcinoma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, HJ; Li, M; Li, X; Pan, WB; Wang, YQ; Xu, HL; Zhang, MY; Zhang, RJ | 1 |
| Bradshaw, TJ; Forrest, LJ; Jallow, N; Jeraj, R; Yip, S | 1 |
| Dahlman, A; Fröhlich, C; Horak, ID; Jacobsen, HJ; Jensen, MM; Kjaer, A; Kragh, M; Kristensen, LK; Lantto, J; Nielsen, CH; Poulsen, TT | 1 |
| Haba, R; Hagiike, M; Izuishi, K; Kaji, M; Kameyama, R; Murota, M; Nishiyama, Y; Takebayashi, R; Yamamoto, Y | 1 |
| Krause, BJ; Lordick, F; Ott, K | 1 |
| Dietlein, M; Kahraman, D; Kobe, C; Neumaier, B; Nogova, L; Scheffler, M; Thomas, R; Wolf, J; Zander, T | 1 |
| Asher, C; Chu, SK; Garwin, GG; Johnson, BW; Krohn, KA; Li, T; Miyaoka, RS; Plotnik, DA; Schwartz, JL | 1 |
| Grierson, JR; Kolb, PD; Rasey, JS; Schwartz, JL; Wiens, LW | 1 |
| Grierson, JR; Jordan, R; Krohn, KA; Schwartz, JL; Tamura, Y | 1 |
| Grierson, JR; Jordan, R; Krohn, KA; Muzi, M; Schwartz, JL | 1 |
| Binns, D; Conus, N; Cullinane, C; Dorow, DS; Hicks, RJ; McArthur, GA; McCarthy, TJ; Roselt, P | 1 |
| Chang, ST; Chin, F; Dick, DW; Gambhir, SS; Kamaya, A; Koong, AC; Loo, BW; Quon, A | 1 |
1 review(s) available for alovudine and Adenocarcinoma
| Article | Year |
|---|---|
[Positron emission tomography - current role in the diagnosis and treatment of upper gastrointestinal carcinomas].
Topics: Adenocarcinoma; Combined Modality Therapy; Dideoxynucleosides; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
11 other study(ies) available for alovudine and Adenocarcinoma
| Article | Year |
|---|---|
Prediction of tumor biological characteristics in different colorectal cancer liver metastasis animal models using
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Colorectal Neoplasms; Dideoxynucleosides; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Hyaluronan Receptors; Immunohistochemistry; Ki-67 Antigen; Linear Models; Liver Neoplasms; Mice, Nude; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Time Factors; Vascular Endothelial Growth Factor A | 2018 |
Spatiotemporal stability of Cu-ATSM and FLT positron emission tomography distributions during radiation therapy.
Topics: Adenocarcinoma; Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Proliferation; Chondrosarcoma; Coordination Complexes; Dideoxynucleosides; Dog Diseases; Dogs; Dose Fractionation, Radiation; Multimodal Imaging; Nose Neoplasms; Organometallic Compounds; Osteosarcoma; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Thiosemicarbazones; Tomography, X-Ray Computed | 2014 |
In vivo imaging of therapy response to a novel pan-HER antibody mixture using FDG and FLT positron emission tomography.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; ErbB Receptors; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Mice, Nude; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptor, ErbB-2; Receptor, ErbB-3; Time Factors; Tumor Burden; X-Ray Microtomography; Xenograft Model Antitumor Assays | 2015 |
Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cell Proliferation; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2009 |
Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [18F]fluorothymidine (FLT-)PET.
Topics: Adenocarcinoma; Afatinib; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Dideoxynucleosides; DNA Mutational Analysis; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Fatal Outcome; Female; Humans; Lung Neoplasms; Quinazolines; Radionuclide Imaging; Radiopharmaceuticals; Sequence Deletion | 2012 |
Levels of human equilibrative nucleoside transporter-1 are higher in proliferating regions of A549 tumor cells grown as tumor xenografts in vivo.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Biological Transport; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Dideoxynucleosides; Equilibrative Nucleoside Transporter 1; Humans; Lung Neoplasms; Male; Mice; Positron-Emission Tomography; Protein Transport | 2012 |
Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.
Topics: Adenocarcinoma; Cell Cycle; Cell Division; Culture Media; Dideoxynucleosides; Fluorine Radioisotopes; Humans; Lung Neoplasms; Thymidine Kinase; Tumor Cells, Cultured | 2002 |
Effect of p53 activation on cell growth, thymidine kinase-1 activity, and 3'-deoxy-3'fluorothymidine uptake.
Topics: Adenocarcinoma; Cell Division; Cell Line, Tumor; Dideoxynucleosides; Dose-Response Relationship, Radiation; Enzyme Activation; Gamma Rays; Humans; Lung Neoplasms; Thymidine Kinase; Tumor Suppressor Protein p53 | 2004 |
Metabolism of 3'-deoxy-3'-[F-18]fluorothymidine in proliferating A549 cells: validations for positron emission tomography.
Topics: Adenocarcinoma; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Humans; Kinetics; Lung Neoplasms; Metabolic Clearance Rate; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Dideoxynucleosides; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Mice; Morpholines; Positron-Emission Tomography; Prognosis; Protein-Tyrosine Kinases; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tumor Cells, Cultured | 2006 |
Initial evaluation of 18F-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Dideoxynucleosides; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2008 |